Toxic Peptides From Snakes, Insects, and Microbes Share a Common Cell-Killing Structure

Despite coming from phylogenetically distant species, cytolytic peptides converge on a common structural motif: a cationic site flanked by a hydrophobic surface.

Kini, R M et al.·International journal of peptide and protein research·1989·Preliminary EvidenceReview
RPEP-00121ReviewPreliminary Evidence1989RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Cytolytic peptides from diverse species converge on a common structural motif: a cationic site flanked by a hydrophobic surface. This motif is necessary and sufficient for membrane-disrupting activity.

Key Numbers

How They Did This

Comparative sequence analysis of cytolytic peptides from multiple species, supported by evidence from synthetic analogs and chemical modification studies.

Why This Research Matters

Identifying the common structural requirement for cell-killing activity provides a blueprint for designing new antibacterial and anticancer peptides.

The Bigger Picture

Understanding the universal structure for membrane disruption enables rational design of antimicrobial peptides and cancer-killing agents. Nature has converged on one solution to punching holes in cell membranes.

What This Study Doesn't Tell Us

This is a sequence comparison study. The proposed structural motif needs experimental validation in each case. Not all peptides with this motif may be cytolytic.

Questions This Raises

  • ?Can the common motif be minimized for drug design?
  • ?Could selectivity for bacterial vs human membranes be engineered?

Trust & Context

Key Stat:
Convergent evolution Same membrane-disrupting motif in species separated by hundreds of millions of years
Evidence Grade:
Preliminary — comparative sequence analysis review with supporting experimental evidence.
Study Age:
Published in 1989 — identified the universal cytolytic motif guiding peptide drug design.
Original Title:
A common cytolytic region in myotoxins, hemolysins, cardiotoxins and antibacterial peptides.
Published In:
International journal of peptide and protein research, 34(4), 277-86 (1989)
Database ID:
RPEP-00121

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

How do these peptides kill cells?

They insert their hydrophobic surface into the cell membrane while their charged region destabilizes the membrane structure, creating pores that cause the cell to leak and die.

Can this be used for medicine?

Yes — antimicrobial peptides based on this motif are being designed to kill drug-resistant bacteria. The challenge is making them selective for bacterial membranes over human cells.

Read More on RethinkPeptides

Cite This Study

RPEP-00121·https://rethinkpeptides.com/research/RPEP-00121

APA

Kini, R M; Evans, H J. (1989). A common cytolytic region in myotoxins, hemolysins, cardiotoxins and antibacterial peptides.. International journal of peptide and protein research, 34(4), 277-86.

MLA

Kini, R M, et al. "A common cytolytic region in myotoxins, hemolysins, cardiotoxins and antibacterial peptides.." International journal of peptide and protein research, 1989.

RethinkPeptides

RethinkPeptides Research Database. "A common cytolytic region in myotoxins, hemolysins, cardioto..." RPEP-00121. Retrieved from https://rethinkpeptides.com/research/kini-1989-a-common-cytolytic-region

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.